Skip to main content

Table 3 Effect modification of WHTR on incidence of NAFLD

From: The value of the atherogenic index of plasma in non-obese people with non-alcoholic fatty liver disease: a secondary analysis based on a cross-sectional study

Variable

Unadjusted

Adjusted Model I

Adjusted Model II

 

OR (95%CI)

P-value

OR (95%CI)

P-value

OR (95%CI)

P-value

WHTR (Per SD)

52.30(47.64–57.41)

<  0.001

36.57 (33.20–40.29)

<  0.001

50.84 (38.22–67.63)

<  0.001

WHTR (quartile)

 Q1

Reference

 

Reference

 

Reference

 

 Q2

3.18 (2.78–3.63)

<  0.001

2.67 (2.34–3.05)

<  0.001

1.80 (1.56–2.08)

<  0.001

 Q3

7.91 (6.98–8.96)

<  0.001

5.88 (5.18–6.68)

<  0.001

2.74 (2.37–3.18)

<  0.001

 Q4

28.67 (25.41–32.35)

<  0.001

19.64 (17.36–22.23)

<  0.001

5.04 (4.26–5.95)

<  0.001

P for trend

<  0.001

<  0.001

<  0.001

  1. Model I adjusted for sex, age
  2. Model II adjusted for sex, age, GGT, ALT, AST, TP, ALB, GLB, TB, DBIL, BUN, Cr, eGFR, UA, FPG, TC, TG, HDL-c, LDL-c, BMI
  3. CI Confidence interval.SD = 0.29